Genetic Technologies (AU:GTG) has released an update.
Genetic Technologies Limited has announced an extension to the voluntary suspension of its securities as it finalizes funding agreements crucial for its Entitlement Offer and a strategic distribution partnership. This move comes as the company seeks to strengthen its financial standing and market presence in genomics-based health solutions. The suspension is expected to last until November 4, 2024, unless an earlier update is provided.
For further insights into AU:GTG stock, check out TipRanks’ Stock Analysis page.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
